Janssen Search
Search results
First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select FGFR Alterations
Oct 22, 2023 Spain First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor ...
Cracking the Code: How New Clues in Our Blood Could Sharpen Our Understanding of Diseases and Impact How We Treat Them
Cracking the Code: How New Clues in Our Blood Could Sharpen Our Understanding of Diseases and Impact How We Treat Them Nearly 20 years ago, scientific leaders in the United Kingdom began an ambitious endeavor: to create UK Biobank, a uniquely powerful ...
Sustainability – Overview
Helping People Live Longer, Happier, Healthier Lives Sustainability encompasses all of the ways in which we impact the world—by advancing human health and well-being, safeguarding the planet, keeping our business strong and conducting business responsibly ...
Peter Fang
PETER FANG WORLDWIDE VICE PRESIDENT NEUROSCIENCE GLOBAL COMMERCIAL STRATEGY ORGANIZATION Peter Fang is the Worldwide Vice President, Neuroscience Global Commercial Strategy Organization for the Janssen Pharmaceutical Companies of Johnson & Johnson. ...
Neurodegenerative Disorders: Utilizing biomarker sciences to drive disease understanding, patient identification, and accelerated development
Neurodegenerative Disorders: Utilizing biomarker sciences to drive disease understanding, patient identification, and accelerated development We are in the midst of a scientific renaissance in neurodegeneration, driven by growing evidence of overarching ...
Tamas Oravecz, Ph.D.
TAMAS ORAVECZ, Ph.D. SENIOR DIRECTOR HEAD OF EXPLORATORY BIOLOGY Tamas Oravecz, Ph.D., is Senior Director and Head of Exploratory Biology within Janssen BioTherapeutics (JBIO), Janssen Research & Development. He is based at Spring House, PA. His team ...
Data Sciences Overview
The Vision for Data Science at Janssen R&D Data Science and Digital Health are among the most exciting revolutions of our time, transforming how we discover, develop and deliver new therapies and vaccines to advance our ultimate mission of bringing ...
Addressing Pathogens of Global Concern
Pathogens of Global Concern Dedicated to advancing human health with potentially transformational vaccines Article Type: Infectious Diseases & Vaccines Infectious diseases pose a significant and rising threat to humankind and will continue to spread ...
Janssen to Highlight Latest Advances in Retina Portfolio at the European Society of Retina Specialists (EURETINA) 2023 Annual Meeting
Oct 03, 2023 United States Click to Access Audio Press Release Five abstracts to be presented, including new real-world research and data on Janssen’s investigational gene therapy JNJ-1887 RARITAN, N.J., October 3, 2023 – The Janssen Pharmaceutical ...
Discovery & Development
Discovery & Development Our portfolio is fueled by our world-class discovery and development teams and external collaborators. We continue to work to deliver innovative solutions that contribute to the global fight against infectious diseases and ...